Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma

Summary Human plasma contains a fast-acting t-PA inhibitor, which is not identical with α2-antiplasmin or α2-macroglobulin. The concentration of this inhibitor in normal plasma is highly variable, much lower than that of known plasma protease inhibitors, and in the range of physiologically occurring plasma concentrations of t- PA (0-2 IU/ml). The inhibitor binds to concanavalin A-Sepharose, is rather stable when heated, is not precipitated in euglobulin fractions and probably does not originate from platelets. The inhibitor seems to form a 190 Kd complex with t-PA. The relation between this plasma inhibitor and the recently discovered endothelial cell inhibitor is not yet clear.

[1]  V. V. van Hinsbergh,et al.  Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells. , 1983, Biochemical and biophysical research communications.

[2]  E. Mullaart,et al.  A Simple, Sensitive Spectrophotometric Assay for Extrinsic (Tissue-Type) Plasminogen Activator Applicable to Measurements in Plasma , 1982, Thrombosis and Haemostasis.

[3]  E. Vellenga,et al.  A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin. , 1982, Blood.

[4]  C. Korninger,et al.  Neutralization of Human Extrinsic (Tissue-Type) Plasminogen Activator in Human Plasma: No Evidence for a Specific Inhibitor , 1981, Thrombosis and Haemostasis.

[5]  C. Kluft C1-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: its relation to vascular activator in blood and its role in euglobulin fibrinolysis. , 1978, Thrombosis Research.

[6]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.

[7]  B. Bennett,et al.  Inhibitors of Plasminogen Activation in Human Blood , 1976, British journal of haematology.

[8]  V. Gurewich,et al.  The resistance of fibrinogen and soluble fibrin monomer in blood to degradation by a potent plasminogen activator derived from cadaver limbs. , 1975, Blood.

[9]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.